Electronic Journal of General Medicine

• Gül U, Kiliç A, Gönül M, Cakmak SK, Bayis SS. Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 2007;46:1069-72.
• Majewski S, Jablonska S. Why epidermodysplasia verruciformis -a rare genetic disease- has raised such great interest. Int J Dermatol 2004;43:309-11.
• Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer 1978;65:169-82.
• Feltkamp MC, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003;63:2695-700.
• Gross G, Ellinger K, Roussaki A, Fuchs PG, Peter HH, Pfister H. Epidermodysplasia verruciformis in a patient with Hodgkin’s disease: Characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 1988;91:43-8.
• zur HH. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-698
• Yang JT, Liu CZ, Domer P, Iannaccone P. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice. Cancer Detect Prev 1998;22:405-15.
• Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994;5 Suppl 2:29-35.
• Majewski S, Jablonska S. Why epidermodysplasia verruciformis - a rare genetic disease - has raised such great interest. Int J Dermatol 2004;43:309-311.
• Woodworth CD. HPV innate immunity. Front Biosci 2002;7: 2058-71.
• Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990;22:547-66.
• Kirchner H. Immunobiology of human papillomavirus infection. Prog Med Virol 1986;33:1-41.
• Oldak M, Majewski S, Grzela T, et al. Natural cellmediated cytotoxicity of peripheral blood lymphocytes against target cells transfected with epidermodysplasia verruciformis-specific human papillomavirus type 8 L1 DNA sequences. Int J Mol Med 2004;13:187-91.
• Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990;22:547-66.

Vancouver

Karagöz B, Erikçi AA, Karabudak Ö, Bilgi O, Sayan Ö, Küçükkodacı Z, et al. The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient. EUR J GEN MED. 2009;6(2):136-8. https://doi.org/10.29333/ejgm/82655

APA

Karagöz, B., Erikçi, A. A., Karabudak, Ö., Bilgi, O., Sayan, Ö., Küçükkodacı, Z., Türken, O., Kandemir, E. G., & Öztürk, A. (2009). The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient. European Journal of General Medicine, 6(2), 136-138. https://doi.org/10.29333/ejgm/82655

AMA

Karagöz B, Erikçi AA, Karabudak Ö, et al. The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient. EUR J GEN MED. 2009;6(2), 136-138. https://doi.org/10.29333/ejgm/82655

Chicago

Karagöz, Bülent, Alev Akyol Erikçi, Özlem Karabudak, Oğuz Bilgi, Özkan Sayan, Zafer Küçükkodacı, Orhan Türken, Emin Gökhan Kandemir, and Ahmet Öztürk. "The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient". European Journal of General Medicine 2009 6 no. 2 (2009): 136-138. https://doi.org/10.29333/ejgm/82655

Harvard

Karagöz, B., Erikçi, A. A., Karabudak, Ö., Bilgi, O., Sayan, Ö., Küçükkodacı, Z., . . . Öztürk, A. (2009). The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient. European Journal of General Medicine, 6(2), pp. 136-138. https://doi.org/10.29333/ejgm/82655

MLA

Karagöz, Bülent et al. "The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient". European Journal of General Medicine, vol. 6, no. 2, 2009, pp. 136-138. https://doi.org/10.29333/ejgm/82655